US 11793816
Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B
granted A61KA61K31/196A61K31/198
Quick answer
US patent 11793816 (Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B) held by Northwestern University expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/196, A61K31/198, A61K31/427, A61K31/436